Troy M Bremer

Title: The Innovative Contributions of Troy M Bremer

Introduction

Troy M Bremer is a notable inventor based in Dana Point, CA (US). He has made significant contributions to the field of medical technology, particularly in the area of breast cancer treatment. With a total of 14 patents to his name, Bremer's work has the potential to impact the lives of many patients.

Latest Patents

Among his latest patents, Bremer has developed technologies related to the prediction and treatment of ductal carcinoma in situ (DCIS) and invasive breast cancer. One of his patents focuses on methods and compositions that predict whether a subject with DCIS will experience a subsequent breast event, such as a recurrence or invasive cancer. This technology aims to assist healthcare providers in determining the most effective treatment options for their patients. Another significant patent involves a method of selecting treatment for subjects at risk of invasive breast cancer. This innovation allows for the identification of patients who may not respond to standard radiation therapy, enabling them to receive alternative therapies, such as HER2 antibodies.

Career Highlights

Throughout his career, Bremer has worked with various companies, including Metronom Health, Inc. and Prelude Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for breast cancer treatment.

Collaborations

Bremer has collaborated with notable professionals in his field, including Elliot Botvinick and Steven Paul Linke. These partnerships have likely enhanced his research and development efforts, leading to the creation of impactful medical technologies.

Conclusion

Troy M Bremer's contributions to medical technology, particularly in breast cancer treatment, demonstrate his commitment to innovation and improving patient outcomes. His patents reflect a deep understanding of the complexities of cancer treatment and the need for personalized approaches.